Cargando…

Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study

A prospective cohort study was conducted to evaluate long-term safety of tedizolid as suppressive antimicrobial treatment in patients with implant-associated bone and joint infection caused by multidrug-resistant gram-positive pathogens. Seventeen patients received tedizolid with a median duration o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferry, Tristan, Conrad, Anne, Senneville, Eric, Roux, Sandrine, Dupieux-Chabert, Céline, Dinh, Aurélien, Lustig, Sébastien, Goutelle, Sylvain, Briot, Thomas, Pham, Truong-Thanh, Valour, Florent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320277/ https://www.ncbi.nlm.nih.gov/pubmed/34337099 http://dx.doi.org/10.1093/ofid/ofab351

Ejemplares similares

Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study
por: Senneville, Eric, et al.
Publicado: (2020)

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018)

Plasma Cell Infiltration on Histopathological Samples of Chronic Bone and Joint Infections due to Cutibacterium acnes: A series of 21 Cases
por: Trecourt, Alexis, et al.
Publicado: (2020)

400. Comparison of Tolerance and Microbiological Efficacy of Cefepime and Piperacillin/Tazobactam in Combination with Vancomycin as Empirical Antimicrobial Therapy of Prosthetic Joint Infection: A Propensity-Matched Cohort Study
por: Triffault-Fillit, Claire, et al.
Publicado: (2019)

Microbiological Epidemiology Depending on Time to Occurrence of Prosthetic Joint Infection (PJI): Impact on the Empirical Antimicrobial Strategies
por: Ferry, Tristan, et al.
Publicado: (2017)

Subcutaneous Suppressive Antibiotic Therapy for Bone and Joints Infections: Safety and Outcome in a Cohort of 10 Patients
por: Ferry, Tristan, et al.
Publicado: (2017)

Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
por: Goutelle, Sylvain, et al.
Publicado: (2021)

Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study
por: Chabert, Paul, et al.
Publicado: (2022)

Short report: Experiences of Caregivers Participating in a Telehealth Evaluation of Development for Infants (TEDI)
por: Talbott, Meagan R., et al.
Publicado: (2022)

Pubic Osteomyelitis: Epidemiology and Factors Associated with Management Failure in Two French Reference Centers
por: Ferry, Tristan, et al.
Publicado: (2017)

Determinants of methicillin-susceptible Staphylococcus aureusnative bone and joint infection treatment failure: a retrospective cohort study
por: Valour, Florent, et al.
Publicado: (2014)

190. Osteomyelitis Following Mandibular Reconstruction with Free Fibula Flap: A Cohort Study of an Emerging and Complex Bone and Joint Infection
por: javaux, Clément, et al.
Publicado: (2020)

Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
por: Cerioli, Matteo, et al.
Publicado: (2020)

Bone and Joint Infection Involving Corynebacterium spp.: From Clinical Features to Pathophysiological Pathways
por: Chauvelot, Pierre, et al.
Publicado: (2021)

Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center
por: Roux, Sandrine, et al.
Publicado: (2016)

Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
por: Valour, Florent, et al.
Publicado: (2014)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
por: Morris, Dylan R., et al.
Publicado: (2015)

Erratum to: ‘TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial’
por: Morris, Dylan R., et al.
Publicado: (2016)

Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a Two-Stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection (PJI)
por: Ferry, Tristan, et al.
Publicado: (2017)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
por: Heitzmann, Justine, et al.
Publicado: (2022)

Osteocutaneous-flap-related osteomyelitis following mandibular reconstruction: a cohort study of an emerging and complex bone infection
por: Javaux, Clément, et al.
Publicado: (2022)

Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection
por: Ferry, Tristan, et al.
Publicado: (2021)

700 A cohort of pneumococcal bone and joint infections in adult patients
por: Mahieu, Rafael, et al.
Publicado: (2014)

In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
por: Zhang, Huiyun, et al.
Publicado: (2022)

Corynebacterium Bone and Joint Infection (BJI): A Retrospective Cohort Study in a Reference Center for BJI Management
por: Ferry, Tristan, et al.
Publicado: (2017)

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone
por: Zurenko, Gary, et al.
Publicado: (2014)

333. Tedizolid Activity against Gram-Positive Bacterial Isolates Causing Bone and Joint Infections in the United States (2015–2019)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2020)

Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach
por: Ferry, Tristan, et al.
Publicado: (2020)

Tedizolid Phosphate: a Next-Generation Oxazolidinone
por: Rybak, Jeffrey M., et al.
Publicado: (2015)

Tedizolid: new data and experiences for clinical practice
por: Lletí, Miguel Salavert, et al.
Publicado: (2021)

Staphylococcus epidermidis in Orthopedic Device Infections: The Role of Bacterial Internalization in Human Osteoblasts and Biofilm Formation
por: Valour, Florent, et al.
Publicado: (2013)

Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration
por: Peeters, Olivier, et al.
Publicado: (2016)

Interaction Between Staphylococcal Biofilm and Bone: How Does the Presence of Biofilm Promote Prosthesis Loosening?
por: Josse, Jérôme, et al.
Publicado: (2019)

Activity of Tedizolid against Gram-Positive Clinical Isolates Causing Nosocomial- and Community-Acquired Infections in United States Hospitals (2014–2016)
por: Mendes, Rodrigo E, et al.
Publicado: (2017)

Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm
por: Pham, Truong-Thanh, et al.
Publicado: (2022)

Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
por: Cavalli, Zoé, et al.
Publicado: (2018)

Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
por: Flanagan, Shawn, et al.
Publicado: (2014)

Characteristics of Tedizolid Non-susceptible Enterococcal Clinical Isolates
por: Dhand, Abhay, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m1uufmf1nsic1j6abrk2rr4i33